U.S. flag

An official website of the United States government

NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr) AND multiple conditions

Germline classification:
Likely benign (1 submission)
Last evaluated:
Oct 26, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002490321.1

Allele description [Variation Report for NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr)]

NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr)

Gene:
ELAC2:elaC ribonuclease Z 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p12
Genomic location:
Preferred name:
NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr)
HGVS:
  • NC_000017.11:g.12996585C>T
  • NG_015808.1:g.26480G>A
  • NM_001165962.2:c.1501G>A
  • NM_018127.7:c.1621G>AMANE SELECT
  • NM_173717.2:c.1618G>A
  • NP_001159434.1:p.Ala501Thr
  • NP_060597.4:p.Ala541Thr
  • NP_776065.1:p.Ala540Thr
  • NC_000017.10:g.12899902C>T
  • NM_018127.6:c.1621G>A
  • Q9BQ52:p.Ala541Thr
Protein change:
A501T; ALA541THR
Links:
UniProtKB: Q9BQ52#VAR_017428; OMIM: 605367.0002; dbSNP: rs5030739
NCBI 1000 Genomes Browser:
rs5030739
Molecular consequence:
  • NM_001165962.2:c.1501G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_018127.7:c.1621G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_173717.2:c.1618G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Prostate cancer, hereditary, 2 (HPC2)
Identifiers:
MONDO: MONDO:0013872; MedGen: C3539120; Orphanet: 1331; OMIM: 614731
Name:
Combined oxidative phosphorylation defect type 17
Synonyms:
Combined oxidative phosphorylation deficiency 17
Identifiers:
MONDO: MONDO:0014190; MedGen: C3809526; Orphanet: 369913; OMIM: 615440

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002802792Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Oct 26, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002802792.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024